Results 221 to 230 of about 354,322 (345)

Suspected central nervous system involvement in multiple myeloma on MRI. [PDF]

Radiol Case Rep
Andrade Melchiori F, Christoffersen MN, Foufa K.   +2 more
europepmc   +1 more source

Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies [PDF]

, 2010
Prashant Kapoor, Rafaël Fonseca, S. Vincent Rajkumar, Shirshendu Sinha, Morie A. Gertz, A. Keith Stewart, P. Leif Bergsagel, Martha Q. Lacy, David D. Dingli, Rhett P. Ketterling, Francis K. Buadi, Robert A. Kyle, Thomas E. Witzig, Philip R. Greipp, Angela Dispenzieri, Shaji Kumar   +15 more
openalex   +1 more source

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review

British Journal of Haematology, EarlyView.
This systematic review of 55 trials reveals significant inconsistency in defining transplant ineligibility for multiple myeloma. Arbitrary age cut‐offs predominantly drive exclusion, while validated frailty tools and specific comorbidities are frequently underutilized.
Karun Neupane, Mitch Singstock, Darshi Shah, Riyasha Dahal, Hira Mian, Febe Smith, Rajshekhar Chakraborty, Samer Al Hadidi, Maria Mainou, Ariel Grajales‐Cruz, Syeda Mahrukh Hussnain Naqvi, Kenneth H. Shain, Aaron Goodman, Luciano J. Costa, Muzaffar Qazilbash, Ghulam Rehman Mohyuddin   +15 more
wiley   +1 more source

Extrachromosomal circular DNA of multiple myeloma. [PDF]

J Cancer
Li F, Long X, Tang S, Liu J, Fu Y.
europepmc   +1 more source

Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma

, 2019
Karen Sweiss, Gregory S. Calip, Jeremy J. Johnson, Damiano Rondelli, Pritesh Patel   +4 more
openalex   +2 more sources

Medical haematology: Repositioning haematology at the centre of medicine

British Journal of Haematology, EarlyView.
The complementary domains of Medical Haematology and Haemato‐Oncology share a biological framework. The left panel depicts red cells, platelets, coagulation, thrombosis and innate immunity, while the right panel shows lymphoid and myeloid malignancies.
Cheng Hock Toh, Imelda Bates, Sue Pavord
wiley   +1 more source

Multiple myeloma risk linked to DNA damage response genes. [PDF]

J Hematol Oncol
Conry M, Ostrovnaya I, Kemel Y, Sinha S, Baughn LB, Avery B, Maclachlan K, Groner V, Banaszak L, Norman A, Boddicker NJ, Clay-Gilmour A, Kumar S, Kim E, Dandiker S, Waghmare M, Slager S, Sborov DW, Garber J, Brown EE, Hildebrandt M, Hari P, Camp N, Vachon C, Usmani S, Offit K, Joseph V.   +26 more
europepmc   +1 more source

Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma

Hideki Uryu, Yuko Mishima, Yuko Ishihara, Yuko Shirouchi, Nobuhiko Yamauchi, Mitsuhito Hirano, Kei Hirano, Yukako Teramoto, Kikuaki Yoshida, Dai Maruyama   +9 more
openalex   +2 more sources

PB2104 INHIBITION OF NUCLEOLIN REVERSED BORTEZOMIB RESISTANCE VIA THE REGULATION OF NF‐κB PATHWAY IN MULTIPLE MYELOMA CELLS

, 2019
Jianda Hu, Wenge Liu, Tsung‐Ming Yang, Y. Chen   +3 more
openalex   +1 more source

TrkA abundance is increased in cutaneous nerves in bortezomib‐induced neuropathy

Brain Pathology, EarlyView.
Cutaneous nerves in bortezomib‐induced peripheral neuropathy (BIPN) show reduced nerve fiber density, increased TrkA expression, and enhanced dermal angiogenesis, highlighting a pathological switch in NGF/TrkA signaling that may contribute to nerve damage and pain. Abstract Tropomyosin receptor kinase A (TrkA), a high‐affinity receptor for nerve growth
Yuying Jin, Nadine Cebulla, Daniel Schirmer, Eva Runau, Leon Flamm, Calvin Terhorst, Laura Jähnel, Johanna Güse, Nicola Giordani, Annett Wieser, Julian Brennecke, Annemarie Sodmann, Martin Kortüm, Robert Blum, Claudia Sommer   +14 more
wiley   +1 more source